144
Cartesian Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
148
FY23:
90.7
FY24:
217
FY25:
129
(positive)
Change from FY21 to FY25
millions USD
FY21:
15.4
FY22:
17.7
FY23:
214
FY24:
218
FY25:
167
Total assets
Change from FY21 to FY25
millions USD
FY21:
160
FY22:
166
FY23:
305
FY24:
435
FY25:
296
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
72.3
FY22:
25.1
FY23:
68.2
FY24:
23.0
FY25:
14.9
(negative)
Change from FY21 to FY25
millions USD
FY21:
65.1
FY22:
47.0
FY23:
376
FY24:
419
FY25:
408
(positive)
Change from FY21 to FY25
millions USD
FY21:
22.5
FY22:
93.8
FY23:
−440
FY24:
−6.80
FY25:
−126
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
160
FY22:
166
FY23:
–
FY24:
435
FY25:
296
All amounts in millions USD